Recombinant ITGAL (Efalizumab Biosimilar) anticorps

N° du produit ABIN5668044

Cet anticorps Human Monoclonal détecte spécifiquement ITGAL (Efalizumab Biosimilar) dans BR et FACS. Il présente une réactivité envers Humain.

Aperçu rapide pour Recombinant ITGAL (Efalizumab Biosimilar) anticorps (ABIN5668044)

Antigène: ITGAL (Efalizumab Biosimilar)

Type d'anticorp: Recombinant Antibody

Reactivité: Humain

Hôte: Human

Clonalité: Monoclonal

Conjugué: Cet anticorp ITGAL (Efalizumab Biosimilar) est non-conjugé

Application: Blocking Reagent (BR), Flow Cytometry (FACS)

Clone: Hu1124

Détail du produit anti-ITGAL (Efalizumab Biosimilar) anticorps

Fonction: Anti-CD11a [hu1124 (Efalizumab)], Human IgG1, kappa

Specificité: Binds to human LFA-1.

Attributs du produit:

Original Species of Ab: Human

Original Format of Ab: IgG1

Purification: Protein A affinity purified

Pureté: > 98 % as determined by SDS-PAGE

niveau d'endotoxine: Endotoxin is < 1.0 EU/mg as determined by the LAL method

Immunogène: Efalizumab binds to CD11a, a subunit of leukocyte function antigen-1 (LFA-1), which is expressed on all leukocytes.

Isotype: IgG1 kappa

Information d'application

Indications d'application: Efalizumab binds to the LFA-1 alpha I domain blocking the ICAM-1 binding site via steric hindrance.

Restrictions: For Research Use only

Stockage

Concentration: 1 mg/mL

Buffer: PBS with 0.02 % Proclin 300.

Agent conservateur: ProClin

Précaution d'utilisation: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: 4 °C,-20 °C

Stockage commentaire: Store at 4°C for up to 3 months. For longer storage, aliquot and store at -20°C.

Détails sur ITGAL (Efalizumab Biosimilar)

Antigène: ITGAL (Efalizumab Biosimilar)

Classe de substances: Biosimilar

Sujet: LFA-1, integrin alpha L

UniProt: P20701